Fluzone

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Breast CancerInfluenzaChronic Obstructive Pulmonary DiseaseMemory

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

1

Fluzone

GSK

Approved

12

Lexiscan

Astellas

Preclinical

13

Adenocard

Astellas

Preclinical

14

Blenoxane

Bristol-Myers Squibb

Preclinical

15

Zinecard

CChildren's Oncology Group

Preclinical

26

Sporanox

SSebela Pharmaceuticals Development LLC

Preclinical

17

Feraheme

AAzurity Pharmaceuticals

Preclinical

18

Systemic Therapy

Bristol-Myers Squibb

Preclinical

19

Zoladex

Luye Pharma Group Ltd.

Preclinical

810

Apatinib Mesylate

BBukwang Pharmaceutical

Preclinical

3Show 15 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Influenza37 trials

Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 4·NCT00138385·40 enrolled

Strategies for Enhancing Mucosal Immunity to Influenza Vaccine

Completed·JJohn Sundy·Phase 1·NCT01385215·60 enrolled

Influenza Vaccine in Pregnant Women

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00905125·102 enrolled

Show 34 more trials

Immune Responses Induced by Different Licensed Influenza Vaccines

Completed·UUniversity of Massachusetts, Worcester·N/A·NCT00902278·193 enrolled

Intradermal Influenza Vaccination

Recruiting·YYale University·Phase 1·NCT06067555·249 enrolled

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age

Completed·GSK·Phase 3·NCT02242643·2,432 enrolled

Safety Study of Live Attenuated Influenza Vaccine, CodaVax

Completed·CCodagenix, Inc·Phase 1·NCT03926416·125 enrolled

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

Unknown status·VVaxInnate Corporation·Phase 2·NCT02434276·450 enrolled

Comparison of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

Terminated·FFatimah Dawood·Phase 4·NCT05514002·3,988 enrolled

Influenza Immunity Against Pandemic Respiratory Virus

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 4·NCT00138281·60 enrolled

The Human Mucosal Immune Responses to Influenza Virus (SLVP026)

Completed·SStanford University·Phase 4·NCT03023553·13 enrolled

Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children

Completed·GSK·Phase 3·NCT00764790·3,317 enrolled

Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032)

Terminated·SStanford University·Phase 4·NCT03023709·3 enrolled

Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)

Terminated·SStanford University·Phase 4·NCT03028987·10 enrolled

B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)

Completed·SStanford University·Phase 4·NCT03020498·91 enrolled

Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children

Completed·MMcMaster University·Phase 4·NCT02871206·3,425 enrolled

Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children

Completed·GSK·Phase 3·NCT00980005·2,116 enrolled

Young Adult Influenza Vaccine Immunogenicity Substudy

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT00170508·15 enrolled

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

Recruiting·UUniversity of Alabama at Birmingham·Phase 4·NCT04101838·50 enrolled

Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals

Completed·UUniversity of Pennsylvania·Phase 4·NCT01262846·195 enrolled

Immunogenicity and Safety of Different Doses of Fluzone® Influenza

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00253734·217 enrolled

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients

Completed·YYale University·Phase 1·NCT02267733·51 enrolled

Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)

Completed·SStanford University·Phase 4·NCT03028974·77 enrolled

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

Completed·CCenters for Disease Control and Prevention·Phase 4·NCT03722589·944 enrolled

Comparison of Three Licensed Influenza Vaccines

Completed·UUniversity of Rochester·Phase 4·NCT03068949·413 enrolled

A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

Completed·VVaxart·Phase 2·NCT02918006·179 enrolled

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age

Completed·GSK·Phase 2·NCT01974895·316 enrolled

Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)

Completed·SStanford University·Phase 4·NCT02141581·86 enrolled

A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001

Completed·LLiquidia Technologies, Inc.·Phase 1/2·NCT01224262·152 enrolled

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009

Completed·SStanford University·Phase 4·NCT01987349·72 enrolled

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010

Completed·SStanford University·Phase 4·NCT03022396·82 enrolled

B-cell Immunity to Influenza (SLVP017)- Year 5, 2013

Completed·SStanford University·Phase 4·NCT03020537·8 enrolled

Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4

Completed·UUniversity of Michigan·Phase 4·NCT00538512·1,952 enrolled

Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth

Completed·IInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group··NCT01484522·149 enrolled

Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)

Completed·SStanford University·Phase 4·NCT01831934·22 enrolled

Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00231920·23 enrolled

Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children

Completed·GSK·Phase 3·NCT00383123·3,327 enrolled

Immunogenicity3 trials

A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist

Completed·NNational Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00231907·56 enrolled

A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV

Completed·MMount Sinai Hospital, Canada·Phase 1/2·NCT02263040·170 enrolled

Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults

Completed·GSK·Phase 3·NCT01389479·1,000 enrolled

Vaccine Response2 trials

Systems Investigation of Vaccine Responses in Aging and Frailty

Recruiting·YYale University·Phase 2·NCT05291676·96 enrolled

Effects of Aging on Primary and Secondary Vaccine Responses

Completed·SStanford University·Phase 1·NCT03312699·54 enrolled

Adult1 trial

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Completed·NNovavax·Phase 3·NCT04120194·2,654 enrolled

Breast Cancer1 trial

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

Withdrawn·RRush University Medical Center·Phase 1·NCT06229392

Details

Drug Info

Related News